HUP9904191A2 - Szuboxidegységekből előállított makrociklusos vegyületek - Google Patents

Szuboxidegységekből előállított makrociklusos vegyületek

Info

Publication number
HUP9904191A2
HUP9904191A2 HU9904191A HUP9904191A HUP9904191A2 HU P9904191 A2 HUP9904191 A2 HU P9904191A2 HU 9904191 A HU9904191 A HU 9904191A HU P9904191 A HUP9904191 A HU P9904191A HU P9904191 A2 HUP9904191 A2 HU P9904191A2
Authority
HU
Hungary
Prior art keywords
macrocyclic
com
active ingredient
substance
active
Prior art date
Application number
HU9904191A
Other languages
English (en)
Hungarian (hu)
Inventor
Franz Kerek
Original Assignee
Donatur Dr. Kerek Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donatur Dr. Kerek Gmbh filed Critical Donatur Dr. Kerek Gmbh
Publication of HUP9904191A2 publication Critical patent/HUP9904191A2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Rehabilitation Therapy (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
HU9904191A 1996-01-05 1996-12-30 Szuboxidegységekből előállított makrociklusos vegyületek HUP9904191A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19600301A DE19600301C2 (de) 1996-01-05 1996-01-05 Durch Cyclooligomerisierung des einfachen Kohlensuboxids C¶3¶O¶2¶ aufgebaute makrocyclische Verbindungen, Verfahren zu deren Herstellung und Gewinnung sowie deren Verwendung

Publications (1)

Publication Number Publication Date
HUP9904191A2 true HUP9904191A2 (hu) 2000-05-28

Family

ID=7782233

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904191A HUP9904191A2 (hu) 1996-01-05 1996-12-30 Szuboxidegységekből előállított makrociklusos vegyületek

Country Status (26)

Country Link
US (1) US6187810B1 (enExample)
EP (1) EP0874851B1 (enExample)
JP (1) JP4195089B2 (enExample)
KR (1) KR19990077000A (enExample)
CN (1) CN1209132A (enExample)
AR (1) AR005350A1 (enExample)
AT (1) ATE233768T1 (enExample)
AU (1) AU1307497A (enExample)
BG (1) BG102599A (enExample)
BR (1) BR9612430A (enExample)
CA (1) CA2241870A1 (enExample)
CZ (1) CZ208898A3 (enExample)
DE (2) DE19600301C2 (enExample)
EE (1) EE9800211A (enExample)
ES (1) ES2194128T3 (enExample)
HR (1) HRP970002A2 (enExample)
HU (1) HUP9904191A2 (enExample)
IL (1) IL125165A0 (enExample)
JO (1) JO1945B1 (enExample)
PL (1) PL327657A1 (enExample)
SI (1) SI0874851T1 (enExample)
SK (1) SK88598A3 (enExample)
TR (1) TR199801288T2 (enExample)
TW (1) TW376386B (enExample)
WO (1) WO1997025333A2 (enExample)
ZA (1) ZA9714B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO280796A0 (en) * 1996-10-07 1996-10-31 Austin Research Institute, The Methods of activating or enhancing FC receptors
DE10260537A1 (de) 2002-12-21 2004-07-15 Kerek, Franz, Dr. Peptide mit hohem Cysteingehalt
US20060067055A1 (en) * 2004-09-30 2006-03-30 Heffner Kenneth H Thermally conductive composite and uses for microelectronic packaging
US20080007890A1 (en) * 2004-09-30 2008-01-10 Harmon Julianne P Thermally conductive composite and uses for microelectronic packaging
CN119613750B (zh) * 2024-12-10 2025-08-12 杭州师范大学 一种机械及pH双重调控的蝶形钾离子通道分子及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565115A (en) 1948-10-28 1951-08-21 Squibb & Sons Inc Method of obtaining a conjugated estrogen preparation
US2720483A (en) 1951-02-21 1955-10-11 Olin Mathieson Method of obtaining a conjugatedestrogen preparation

Also Published As

Publication number Publication date
DE69626548D1 (de) 2003-04-10
WO1997025333A2 (en) 1997-07-17
US6187810B1 (en) 2001-02-13
BR9612430A (pt) 1999-12-28
ES2194128T3 (es) 2003-11-16
SK88598A3 (en) 1998-12-02
AU1307497A (en) 1997-08-01
ZA9714B (en) 1997-07-23
DE69626548T2 (de) 2003-12-24
TR199801288T2 (xx) 1998-11-23
WO1997025333A3 (en) 1997-12-24
DE19600301C2 (de) 1999-12-09
PL327657A1 (en) 1998-12-21
TW376386B (en) 1999-12-11
SI0874851T1 (en) 2003-10-31
CN1209132A (zh) 1999-02-24
JO1945B1 (en) 1997-12-15
IL125165A0 (en) 1999-01-26
KR19990077000A (ko) 1999-10-25
CA2241870A1 (en) 1997-07-17
ATE233768T1 (de) 2003-03-15
EP0874851B1 (en) 2003-03-05
AR005350A1 (es) 1999-04-28
JP2000503015A (ja) 2000-03-14
HRP970002A2 (en) 1998-04-30
BG102599A (en) 1999-03-31
JP4195089B2 (ja) 2008-12-10
EP0874851A2 (en) 1998-11-04
EE9800211A (et) 1998-12-15
DE19600301A1 (de) 1997-07-10
CZ208898A3 (cs) 1998-10-14

Similar Documents

Publication Publication Date Title
IKEKAwA et al. Antitumor activity of Hypsizigus marmoreus. I. Antitumor activity of extracts and polysaccharides
Srivastava et al. Synthesis and antitumor activity of 2-. beta.-D-ribofuranosylselenazole-4-carboxamide and related derivatives
JPH01157995A (ja) 鎮痛−抗炎症活性を有するガングリオシドの内部エステル
US4663438A (en) Novel nucleic acid-containing glycoprotein
US20050084903A1 (en) Lectin protein prepared from maackia fauriei, process for preparing the same and the use thereof
WO1991004258A1 (fr) Derive d'ionisotol et production de ce derive
HUP9904191A2 (hu) Szuboxidegységekből előállított makrociklusos vegyületek
WO2001049308A1 (en) Novel immune enhancing compositions
CN109053682B (zh) 一种tdo小分子抑制剂衍生物及其抗肿瘤偶联物和制备方法
US5856487A (en) Application of protoberberine alkaloid, berberine, an immunosuppressive agent
KR101138438B1 (ko) 스피루리나로부터 클로로필 a 및 광민감제 제조방법
RU2027434C1 (ru) Иммуномодулирующее средство
SU1056901A3 (ru) Способ получени сесквитерпеновых производных или их солей
KR101106756B1 (ko) 스피루리나로부터 클로로필 a 및 광민감제 제조방법
RU2644332C1 (ru) Способ получения растительного лектина ml1 из омелы белой и фармацевтическая композиция на его основе (варианты).
CN113166188A (zh) 两性霉素b肽衍生物
KR101138437B1 (ko) 스피루리나로부터 클로로필 a 및 광민감제 제조방법
US5656601A (en) Acylated splenopentins, methods for their synthesis and their use
JP2001515861A (ja) 抗腫瘍薬としてのジチオロピロロンおよびそれらの対応するモノオキサイドおよびジオキサイド
CN1137129C (zh) 裂褶四糖簇合物及其制备方法和应用
CN119119208A (zh) Buforin llb或其衍生肽作为ARF6抑制剂及应用
JP2000103789A (ja) プロポリス由来のベンゾピラン誘導体の生理活性
RU98114845A (ru) Макроциклические соединения, полученные из субоксидных единиц
KR20120016573A (ko) 스피루리나로부터 클로로필 a 및 광민감제 제조방법
JP2000212196A (ja) 生理活性物質dm9809およびこれを有効成分とする医薬